Intelligent Bio Solutions (INBS) Return on Capital Employed (2021 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Return on Capital Employed of 226.74% in Q1 2025, down 22.32% quarter-over-quarter from 185.37% in Q4 2024, and down 8596.0% on a YoY basis from 2.67% in Q1 2024.
Intelligent Bio Solutions (INBS) Return on Capital Employed (2021 - 2025) Analysis & Trends
Intelligent Bio Solutions' Return on Capital Employed history runs 5 years deep, the most recent figure standing at 226.74% for Q1 2025.
- In Q1 2025, Return on Capital Employed fell 8596.0% year-over-year to 226.74%; the TTM figure through Mar 2025 stood at 226.74% (down 8596.0% YoY), while the FY2024 annual figure was 155.43%, up 7484.0% from the prior year.
- Return on Capital Employed was 226.74% for Q1 2025 at Intelligent Bio Solutions, down from 185.37% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 9.8% in Q1 2021 to a low of 518.47% in Q3 2023.
- Historically, Return on Capital Employed has averaged 151.0% across 5 years, with a median of 103.26% in 2024.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed slumped 42726 bps in 2023, then soared 37028 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 67.61% in 2021, then slipped by 8 bps to 72.99% in 2022, then plunged by 427 bps to 384.39% in 2023, then soared by 52 bps to 185.37% in 2024, then dropped by 22 bps to 226.74% in 2025.
- The last three Return on Capital Employed figures came in at 226.74% (Q1 2025), 185.37% (Q4 2024), and 148.19% (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 9.30% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 24.24% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 11.57% |
| 10 | Intelligent Bio Solutions | 12.72 Mn | 11.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -226.74% |
| Dec 31, 2024 | -185.37% |
| Sep 30, 2024 | -148.19% |
| Jun 30, 2024 | -103.26% |
| Mar 31, 2024 | -140.78% |
| Dec 31, 2023 | -384.39% |
| Sep 30, 2023 | -518.47% |
| Jun 30, 2023 | -272.15% |
| Mar 31, 2023 | -110.70% |
| Dec 31, 2022 | -72.99% |
| Sep 30, 2022 | -91.20% |
| Jun 30, 2022 | -95.91% |
| Mar 31, 2022 | -68.51% |
| Dec 31, 2021 | -67.61% |
| Sep 30, 2021 | -35.97% |
| Jun 30, 2021 | -34.89% |
| Mar 31, 2021 | -9.80% |